友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
MOLECULAR PHARMACEUTICS
Mol. Pharmaceutics
ISSN / eISSN
1543-8384 / 1543-8392
目标和范围
Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:
Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
研究方向
药学
医学：研究与实验
CiteScore
9.20
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science | Q1 | #24/171 |
| Pharmacology, Toxicology and Pharmaceutics - Drug Discovery | Q1 | #26/156 |
| Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q1 | #40/171 |
Web of Science 核心合集
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2023) | 分区 |
|---|---|
| MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q2 |
| PHARMACOLOGY & PHARMACY - SCIE | Q1 |
H-index
110
出版国家或地区
UNITED STATES
出版商
American Chemical Society
出版周期
Monthly
出版年份
2004
年文章数
440
Open Access
NO
通讯方式
AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036
认证评论
In the first month, one rejection, one major revision, and four minor revisions.
Two months later, the revised manuscript was submitted.
Another month passed with two minor revisions and four approvals.
In the final week, the revisions were completed and accepted directly.
In total, it took four months from start to finish.
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now